Find the TRUMENBA vaccine near you Use my current location Find it! TRUMENBA is an FDA-approved vaccine for meningitis B (also known as MenB)1 MenB is an uncommon but potentially deadly disease that progresses quickly and can lead to death within 24 hours.2,3 There are multiple strains ...
Oct 29, 2014ApprovalFDA Approves Trumenba - First Vaccine to Prevent Serogroup B Meningococcal Disease See also Trumenba (meningococcal group B vaccine) Consumer information Further information Always consult your healthcare provider to ensure the information displayed on this page applies to your personal...
according to the researchers. The CDC’s Advisory Committee on Immunization Practices (ACIP) currently recommends the vaccine be routinely given to at-risk persons aged older than 10 years, and considered for those aged 16 to 23 ye...
FDA Approves Trumenba Vaccine for Serogroup B MeningitisRajaraman, Madhu
TRUMENBA™(Meningococcal Group B Vaccine) This product information is intended only for residents of the United States. for Consumers: TRUMENBA™ - U.S. Medical Information Page - patient information, ways to contact Pfizer Medical & other resources ...
商品名 TRUMENBA 通用名 meningococcal B rLP2086 vaccine 企业名称 Pfizer(辉瑞) 销售额(万元/RMB) 73247 销售额(原始) 112 货币单位(原始) 百万美元 年份 2020 畅销药品数据分析 全球畅销药品销售数据分析 暂无权限!更多信息,升级会员权限,立即享受 扩展信息 ...
MenB-FHbp (bivalent rLP2086; Trumenba®) is a recombinant protein-based vaccine targeting Neisseria meningitidis serogroup B (MenB), which has recently been licensed in the EU for active immunization tDOI: 10.1007/s40265-018-0869-7 年份...
MenB-FHbp Meningococcal GroupB Vaccine (Trumenba): A Review in Active Immunization in Individuals Aged≥10YearsMenB-FHbp (bivalent rLP2086; Trumenba®) is a recombinant protein-based vaccine targeting Neisseria meningitidis serogroup B (MenB), which has recently...
doi:10.1016/j.vaccine.2020.04.074Olof SllEmma OlofssonSusanne JacobssonVaccine
Bivalent rLP2086 vaccine (Trumenba(R)): a review in active immunization against invasive meningococcal group B disease in individuals aged 10-25 years. ... M Shirley,S Dhillon - 《Biodrugs Clinical Immunotherapeutics Biopharmaceuticals & Gene Therapy》 被引量: 15发表: 2015年 Bivalent rLP2086 Vac...